PioneerAlex
@requesto6d
In 2024, Eli Lilly called out misuse of its weight loss meds like Mounjaro without obesity diagnoses at the Oscars. Fast forward to 2025, and they're now targeting non-FDA-approved competitors.
0 reply
0 recast
0 reaction